相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis of a series of caffeic acid phenethyl amide (CAPA) fluorinated derivatives: Comparison of cytoprotective effects to caffeic acid phenethyl ester (CAPE)
John Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials
Jie Fu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Selective Matrix Metalloproteinase Inhibitors for Cancer
Nian-Guang Li et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Sulfonamide chalcone as a new class of α-glucosidase inhibitors
WD Seo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Evaluation of caffeic acid amide analogues as anti-platelet aggregation and anti-oxidative agents
CC Hung et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus:: isolation and structure determination
WH Park et al.
TOXICOLOGY (2005)
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism
TW Chung et al.
FASEB JOURNAL (2004)
Development and validation of a liquid chromatographic-tandem mass spectrometric method for the determination of caffeic acid phenethyl ester in rat plasma and urine
N Celli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26-L5 carcinoma cell line
T Nagaoka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Synthesis and evaluation of caffeic acid amides as antioxidants
P Rajan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
A versatile assay for gelatinases using succinylated gelatin
VM Baragi et al.
MATRIX BIOLOGY (2000)
Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases
R Scatena
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
分享论文
